Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA has approved AUSTEDOâ„¢ (deutetrabenazine) tablets for the treatment of chorea associated...
Read moreAscendis Pharma A/S ,biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases...
Read moreIntralytix, Inc. announced that the Company is partnering with BioPhage Therapeutics Limited to develop and commercialize topical bacteriophage treatments of...
Read moreNeurim Pharmaceuticals and Exeltis announced a license agreement in which Exeltis will obtain exclusive marketing rights for Neurim’s new Rx...
Read moreTo help address the challenges surrounding supply chain management for cell and gene therapy around the globe, Thermo Fisher Scientific,...
Read moreQR Pharma, Inc., a privately held phase 2 biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s (AD), Parkinson’s...
Read moreEMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, and Pfizer Inc. announced that...
Read moreLiquid Learning is delighted to present the Women in Pharma and Medical Leadership Summit. A unique platform in New Zealand...
Read moreResearchers from Epinomics will collaborate with the research team led by Crystal Mackall, MD, director of the Parker Institute for...
Read moreZimmer Biomet Holdings Inc , a global leader in musculoskeletal healthcare announced that the U.S. FDA approved an expanded 26-week...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.